Pluri Inc. (PLUR) Debt Components
- 2022-06-30: Line of Credit Facility, Maximum Borrowing CapacityEUR (m); Debt Instrument, Face AmountEUR (m); Long-term Debt, Current MaturitiesUSD (m); Long-term Debt and Lease ObligationUSD (m).
- 2021-12-31: Line of Credit Facility, Maximum Borrowing CapacityEUR (m); Debt Instrument, Face AmountEUR (m); Long-term Debt, Current MaturitiesUSD (m); Long-term Debt and Lease ObligationUSD (m).
- 2021-09-30: Line of Credit Facility, Maximum Borrowing CapacityEUR (m); Debt Instrument, Face AmountEUR (m); Long-term Debt, Current MaturitiesUSD (m); Long-term Debt and Lease ObligationUSD (m).
- 2021-06-30: Line of Credit Facility, Maximum Borrowing CapacityEUR (m); Debt Instrument, Face AmountEUR 20.00M; Long-term Debt, Current MaturitiesUSD (m); Long-term Debt and Lease ObligationUSD (m).
Pluri Inc. Debt Components
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Line of Credit Facility, Maximum Borrowing Capacity EUR | Debt Instrument, Face Amount EUR | Long-term Debt, Current Maturities USD | Long-term Debt and Lease Obligation USD | Debt Instrument, Interest Rate, Stated Percentage pure |
|---|---|---|---|---|---|
| 2022-06-30 | (m) | (m) | (m) | (m) | 4.00% |
| 2021-12-31 | (m) | (m) | (m) | (m) | 4.00% |
| 2021-09-30 | (m) | (m) | (m) | (m) | 4.00% |
| 2021-06-30 | (m) | 20.00M | (m) | (m) | (m) |
| 2021-06-30 | (m) | (m) | (m) | (m) | 4.00% |
| 2020-06-30 | (m) | (m) | (m) | $1.26M | (m) |
| 2020-04-30 | 50.00M | (m) | (m) | (m) | (m) |
| 2020-03-31 | (m) | (m) | (m) | $1.26M | (m) |
| 2019-12-31 | (m) | (m) | (m) | $1.26M | (m) |
| 2019-09-30 | (m) | (m) | (m) | $1.26M | (m) |
| 2012-06-30 | (m) | (m) | $13.00K | (m) | (m) |
| 2011-06-30 | (m) | (m) | $60.00K | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B |